Patents
Patents for C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643)
06/2005
06/01/2005CN1621402A Extraction and purification process of ferulic acid
05/2005
05/26/2005WO2005047236A1 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
05/26/2005US20050113454 Anti-viral compounds
05/26/2005US20050113453 Development of new selective estrogen receptor modulators
05/26/2005US20050113440 Compounds that modulate PPAR activity and methods for their preparation
05/26/2005US20050113400 Novel benzophenone derivatives or salts thereof
05/26/2005US20050113366 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of $g(g)-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses
05/25/2005CN1618785A Production technology of 2-methyl-4-chloro-sodium phenoxy acetate
05/25/2005CN1203042C Preparation of optical pure D-malic acid
05/24/2005US6897337 Labeling with methyl iodide
05/24/2005CA2099162C Method and composition for inhibiting silica and silicate deposition
05/19/2005WO2005044919A1 Mixture of fluorinated polyethers and use thereof as surfactant
05/19/2005WO2005044773A1 Rare earth metal compound in aqueous solvent, method for producing same, and method for producing ceramic powder using same
05/19/2005WO2005012233A8 Meldonium salts, method of their preparation and pharmaceutical composition on their basis
05/19/2005WO2005012220A9 Cycloalkylidene compounds as modulators of estrogen receptor
05/19/2005US20050107469 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
05/19/2005US20050107392 treatment of disease such as diabetes, obesity, hyperlipidemia, and atherosclerotic disease; e.g. ethyl (5-methoxy-2,3-dihydro-1H-inden-1-ylidene)ethanoate
05/19/2005US20050107347 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
05/19/2005US20050107281 Ether carboxylic acids based on alkoxylated styrylphenols
05/18/2005CN1617849A Hiv整合酶抑制剂 Hiv integrase inhibitors
05/18/2005CN1616411A Novel chiral amino acid derivative and its synthetic method and use
05/18/2005CN1202103C Preparation method of red sageroot total phenolic acid
05/18/2005CN1202068C Aspirin-triggered lipid mediators
05/18/2005CN1202067C Method for preparing medicinal grade ferric citrate
05/17/2005US6894190 Process for producing optically active 3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid, and salt thereof
05/17/2005US6894187 Method for producing a fluorine-containing compound
05/17/2005US6894160 Converting sugars such as glucose and fructose into industrial useful products via hydrogenation and reductive amination using platinum catalyst formed from stabilized nanoparticles
05/12/2005WO2005042509A1 7-`(7-alkoxy)-chrom-3-en-6-yl!-heptatrienoic acid and 7-`(3­alkoxy)-5,6-dihydronaphthalen-2-yl!-heptatrienoic acid derivatives modulators
05/12/2005WO2005042478A2 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
05/12/2005WO2005041946A1 Development of new selective estrogen receptor modulators
05/12/2005WO2004092145A8 Alpha substituted carboxylic acid as ppar modulators
05/12/2005CA2539446A1 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
05/11/2005EP1528909A1 Trihydroxy polyunsaturated eicosanoids
05/11/2005CN1200703C Use of pentanoate derivant
05/10/2005CA2303801C Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
05/06/2005WO2005040246A1 Acyloxy acetic acid polymer and method for producing same
05/06/2005WO2005040104A1 Novel compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
05/06/2005CA2538630A1 Novel compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
05/05/2005US20050096480 Novel process for producing 1,2-diol
05/05/2005US20050096380 For therapy of diabetes
05/05/2005US20050096244 Mixture of fluorinated polyethers and use thereof as surfactant
05/04/2005EP1527034A1 A process for the optical resolution of a precursor of sclareolide
05/04/2005CN1612852A Lipoxin A4 analogs
05/04/2005CN1612729A 2-aryl-propionic acid and medicine composition containing same
05/04/2005CN1611479A Oxy-carbonyl compound for activating bleaching agent and bleachcing agent composition containing same
05/03/2005US6888033 Contacting picornavirus with 2,6-dihydroxy acetophenone or its salt to inhibit replication of picornavirus
05/03/2005US6887901 Lipoxin compounds and their use in treating cell proliferative disorders
05/03/2005US6887896 7-[(7-Alkoxy)-chrom-3-en-6-yl]-heptatrienoic acid and 7-[(3-alkoxy)-5,6-dihydronaphthalen-2-yl]-heptatrienoic acid derivatives having serum glucose reducing activity
04/2005
04/28/2005WO2005037763A1 Phenoxyether derivatives as ppar modulators
04/28/2005US20050090555 Compound for the treatment of metabolic disorders
04/28/2005US20050090484 Purification of natural, synthetic or semi-synthetic crude harringtonines by reverse phase chromatography and crystallization; solvent is water or lower alkanol, or an aqueous mixture of organic solvents; enantiomerically pure; industrial scale; leukemia chemotherapy
04/28/2005CA2541751A1 Phenoxyether derivatives as ppar modulators
04/27/2005EP1525177A1 Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
04/27/2005EP1370513B1 Malic acid addition salts of terbinafine
04/27/2005CN1198782C Pure beta-hydroxyethoxyacetic acid salt, pure 2-p-dioxaneone, and prodn. method thereof
04/26/2005US6884821 Alkyloxypropanoic acid derivative containing sulfonamide or amide group are useful as insulin resistance agent
04/26/2005US6884820 Antidiabetic agents; side effect reduction
04/26/2005CA2053253C New aryl-and heteroarylethenylene derivatives and process for their preparation
04/21/2005WO2005023741A3 Pharmaceutical compositions containing (+) cannabidiol and derivatives thereof and some such novel derivatives
04/21/2005WO2004098582A3 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions
04/21/2005US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
04/20/2005EP1173400A4 Process for the preparation of 3,4-dihydroxybutanoic acid and derivatives thereof from substituted pentose sugars
04/20/2005EP1165495B1 Resorcinol derivatives
04/20/2005EP1089968B1 Thyroid hormone analogues and methods for their preparation
04/20/2005EP0766669B1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
04/20/2005CN1608093A Crystalline polyglycolic acid, polyglycolic acid composition and production process thereof
04/20/2005CN1608055A Compounds for the treatment of metabolic disorders
04/14/2005WO2005033056A2 Triphenylethylene compounds as selective estrogen receptor modulators
04/14/2005US20050080291 Contiuous direct synthesis from perfluoroolefins or ketones and carbonyl fluoride; haloacylation catalyst of CsF, RbF, KF, or AgF on porous support; improved selectivity and yield
04/13/2005EP1521733A1 Modulators of the glucocorticoid receptor
04/13/2005CN1605583A Process for removing tropina of 2-keto-L-guleonic acid fermentation liquid
04/12/2005CA2157038C Plant growth promoter
04/07/2005WO2005030972A1 Process for producing 3-hydroxypropionaldehyde
04/07/2005WO2005030694A1 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
04/07/2005US20050075338 5-(Substituted oxazolyl- or thiazolyl-ethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases
04/07/2005CA2539403A1 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
04/06/2005EP1519909A1 Polyene carboxylic acid derivatives, method for their production and the use thereof
04/06/2005EP1519908A2 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
04/06/2005CN1603298A Process for extracting lactic acid from fermentation liquid
04/06/2005CN1603291A Novel intermediates useful for the preparation of antihistaminic piperidine derivatives
04/06/2005CN1602762A Novel souring agent
04/06/2005CN1195413C Flower initiation inducer
04/05/2005US6875780 Compounds that modulate PPAR activity and methods for their preparation
04/05/2005US6875775 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
03/2005
03/31/2005US20050070583 Novel compounds, their preparation and use
03/30/2005EP1517680A1 Benzoic acid derivatives as modulators of ppar alpha and gamma
03/30/2005EP1436007B1 Compounds for use as surfactants
03/30/2005CN1602298A Synthesis of oxygen-substituted benzocycloheptenes, used as valuable intermediate products for producing tissue-selective oestrogens
03/30/2005CN1602291A Novel bensophenone derivatives or salts thereof
03/30/2005CN1194674C Novel diphenylethylene compounds
03/24/2005WO2005012220A3 Cycloalkylidene compounds as modulators of estrogen receptor
03/24/2005WO2004099279A3 Heat activated tertiary amine urethane catalysts
03/24/2005WO2004071426A3 Compounds for the treatment of viral infection
03/24/2005US20050063999 Use of at least one (dihydro)jasmonic acid derivative as a desquamating agent
03/24/2005CA2788502A1 Non-peptide agonists and antagonists of adrenomedullin and gastric releasing peptide
03/24/2005CA2539366A1 Process for the production of alpha-alkoxy/hydroxy-beta-(p-hydroxyphenyl) propionic acid derivatives
03/23/2005EP1091924A4 Novel retinoids and use thereof
03/22/2005CA2168514C Isocarbacyclin derivatives
03/17/2005WO2005023741A2 Pharmaceutical compositions containing (+) cannabidiol and derivatives thereof and some such novel derivatives
03/17/2005WO2005023267A1 Cyclohexyl prostaglandin analogs as ep4-receptor agonists
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 147